Nu Skin Enterprises, Inc. (NUS) Stock
NUS Key Statistics
About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.
CEO: Ryan S. Napierski. Company website
NUS — Frequently Asked Questions
What is the NUS stock price today?
Nu Skin Enterprises, Inc. (NUS) trades at $3.89, down 3.47% on the day, as of Nov 12, 2026 09:30 UTC.
What is Nu Skin Enterprises, Inc.'s market cap?
Nu Skin Enterprises, Inc. has a market capitalisation of $189.35M, calculated from the live NUS share price and shares outstanding.
What is the P/E ratio of NUS?
NUS has no meaningful price-to-earnings ratio: Nu Skin Enterprises, Inc. lost $4.84 per share over the last twelve months, and a P/E is only defined on positive earnings.
How much revenue does Nu Skin Enterprises, Inc. make?
Nu Skin Enterprises, Inc. generated revenue of $1.32B over the trailing twelve months, which puts the stock at 0.14 times sales.
Does NUS pay a dividend?
Yes. Nu Skin Enterprises, Inc. pays a dividend yielding 2.19% on the current share price.
What is the 52-week range for NUS?
NUS has traded between $3.88 and $11.67 over the past 52 weeks, and the last price is 66.7% below that high.
Is Nu Skin Enterprises, Inc. profitable?
No. Nu Skin Enterprises, Inc. is loss-making, with a net margin of -17.72% over the trailing twelve months.
What is the analyst price target for NUS?
Wall Street analysts rate NUS Hold, with an average price target of $11.00, 182.8% above the current price.
What sector is Nu Skin Enterprises, Inc. in?
Nu Skin Enterprises, Inc. is classified under the Consumer Defensive sector and the Household & Personal Products industry, and is domiciled in US.
Who is the CEO of Nu Skin Enterprises, Inc.?
Ryan S. Napierski is the chief executive of Nu Skin Enterprises, Inc., which employs 2,800 people.
Where can I track NUS in real time?
QFI Terminal shows NUS with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See NUS live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open NUS in Terminal See plans